Efficacy of Rechallenge of Metastatic Renal Cell Carcinoma Patient With Sunitinib After Prior Resistance to Axitinib: Case Report and Review of the Literature

Clin Genitourin Cancer. 2016 Oct;14(5):e525-e527. doi: 10.1016/j.clgc.2016.04.009. Epub 2016 Apr 22.

¹ Department of Medical Oncology, Hôpital Saint-André, University of Bordeaux-CHU Bordeaux, France; University of Bordeaux, Bordeaux, France. Electronic address: [email protected].
² Department of Medical Oncology, Hôpital Saint-André, University of Bordeaux-CHU Bordeaux, France.
³ Department of Medical Oncology, Hôpital Saint-André, University of Bordeaux-CHU Bordeaux, France; University of Bordeaux, Bordeaux, France.
⁴ Department of Urology, Hôpital Pellegrin, University of Bordeaux-CHU Bordeaux, France.

No abstract available

Keywords: Axitinib; Metastatic renal cell carcinoma; Rechallenge; Tyrosine kinase inhibitor; VEGF-R targeted therapy.

Publication types